bioterror News
Most Popular bioterror Story
$50B bioterror program delivers marginal gains
Seven years and more than $50 billion after 9/11, biosecurity experts say the U.S. still has made only marginal progress developing the security measures and new therapeutics needed to protect the... Read more...
Latest Headlines
- August 5, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
